12 min listen
The Lancet Oncology: March 26, 2008
The Lancet Oncology: March 26, 2008
ratings:
Length:
12 minutes
Released:
Mar 26, 2008
Format:
Podcast episode
Description
Editor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early stage breast cancer; how a phase II study investigating yttrium-90 labelled ibritumomab could have an important future role in the treatment of follicular non-Hodgkin lymphoma, and finally the pressing need for increased recruitment of adolescents and young adults in to cancer trials.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Mar 26, 2008
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: August 11, 2008 by The Lancet Oncology in conversation with